Companies are increasingly investing in research and development to address global health challenges, including cancer, genetic disorders, and infectious diseases. The rise of biologics, gene therapy, and CRISPR technology is transforming treatment options, opening new avenues for biotech services, from drug discovery to clinical trials and regulatory consulting. The growing demand for diagnostics, biomanufacturing, and supply chain optimization is enhancing the value proposition for biotech service providers. As biotech companies and research institutions continue to innovate, the demand for specialized services, expertise, and cutting-edge technologies is on the rise. For a deeper understanding of the Biotech Services market landscape, trends, and growth opportunities, explore our detailed market research reports.
Industry Players
- Abbott
- Qiagen
- Bio-Rad Laboratories Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
Industry Players
- Quest Diagnostics Incorporated
- Eurofins Scientific
- Spectra Laboratories, Inc. (Fresenius Medical Care)
- Novartis AG
- Cell Biolabs, Inc.
Industry Players
- Quest Diagnostics
- LabCorp
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
Industry Players
- Thermo Fisher Scientific, Inc.
- Charles River Laboratories International, Inc.
- Laboratory Corp of America Holdings
- Eurofins Scientific
Industry Players
- Cord Blood Corporation
- CBR Systems Inc.
- PerkinElmer Inc. (ViaCord LLC)
- Cryo-Cell International
- Cordlife Group Limited
Industry Players
- Charles River Laboratories
- VGXI, Inc.
- PlasmidFactory GmbH & Co. KG
- Boehringer Ingelheim
- BioCina
Industry Players
- Thermo Fisher Scientific Inc.
- Waters Corporation
- Agilent Technologies, Inc.
- Human Metabolome Technologies, Inc.
Industry Players
- Horizon Discovery
- GlaxoSmithKline
- Sirna Therapeutics, Inc.
- Alnylam Pharmaceuticals